Chennai Meenakshi Multispeciality Hospital Share Price
38.00-0.88 (-2.26%)
-2.74% past 1 Year
Chennai Meenakshi Multispeciality Hospital Ltd offers the following services Cardiologist,Cosmetic and Plastic Surgeon,Diabetologist,Diabetologist and Endocrinologist,Dermatologist,Dentist,ENT,Gastro Surgeon,General Surgeon,Gynecologist,General Medicine,Vascular Surgeon,Minimal Ascess General and Metabolic Tumours Surgeon,Neurologist,Neuro Surgeon,Orthopaedics,Paediatrician, Gastro Entrologist and Opthalmology.The
Corporate filings & documents
Announcements
At its meeting on 1st September 2026 the Board approved several key director related matters: the redesignation of Non Executive Independent Directors Mr. A F Simeon Telfer(DIN: 11879121) and Ms. Sindu Chawla (DIN: 11879201) as Non-Executive Non Independent Directors liable to retire by rotation effective September 1 2026 ; the recommendation of shareholder approval at the ensuing AGM of the re-appointment of Mr. Edward M Prabhakar (DIN: 11237027) Non Executive Director retire by rotation; the re-appointment of Mrs. R. Gomathi (DIN: 02900460) as Managing Director (Chairman capacity) for 3 years from November 11 2026 to November 10 2029 at Rs 1 00 000 per month (not liable to retire by rotation) subject to Special Resolution at the AGM as she is over 70 years of age ; and the re-constitution of the Audit Nomination and Remuneration and Stakeholders Relationship Committees effective September 1 2026 consequent to the director re-designations.
1 day agoPursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 the Board of Directors at its meeting held today September 1 2026 (1:45 PM-6:35 PM) inter-alia approved the following: payment of professional medical consultancy and surgical fees up to ?8 00 000/- per month to Dr. Thanigai Vendan Moorthy CEO & KMP for FY 2026-27 as an arms length Related Party Transaction; re-designation of Mr. A. F. Simeon Telfer and Ms. Sindu Chawla as Non-Executive Non-Independent Directors w.e.f. September 1 2026; recommendation for re-appointment of Mr. Edward M. Prabhakar Director retiring by rotation; re-appointment of Mrs. R. Gomathi as Managing Director for 3 years w.e.f. November 11 2026 subject to shareholder approval; reconstitution of Audit NRC and Stakeholders Relationship Committees w.e.f. September 1 2026; and convening of the 36th AGM on September 30 2026 with Book Closure from September 24 to September 30 2026.
2 days agoPursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 the Board of Directors at its meeting held today September 1 2026 (1:45 PM-6:35 PM) inter-alia approved the following: payment of professional medical consultancy and surgical fees up to ?8 00 000/- per month to Dr. Thanigai Vendan Moorthy CEO & KMP for FY 2026-27 as an arms length Related Party Transaction; re-designation of Mr. A. F. Simeon Telfer and Ms. Sindu Chawla as Non-Executive Non-Independent Directors w.e.f. September 1 2026; recommendation for re-appointment of Mr. Edward M. Prabhakar Director retiring by rotation; re-appointment of Mrs. R. Gomathi as Managing Director for 3 years w.e.f. November 11 2026 subject to shareholder approval; reconstitution of Audit NRC and Stakeholders Relationship Committees w.e.f. September 1 2026; and convening of the 36th AGM on September 30 2026 with Book Closure from September 24 to September 30 2026.
2 days agoThe Board Meeting to be held on 28/08/2026 has been revised to 01/09/2026 The Board Meeting to be held on 28/08/2026 has been revised to 01/09/2026
1 week agoThe Board Meeting to be held on 28/08/2026 has been revised to 01/09/2026 The Board Meeting to be held on 28/08/2026 has been revised to 01/09/2026
1 week agoChennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on 28th August 2026 Friday at the Registered Office of the Company situated at New. No. 70 Old No.149 Luz Church Road Mylapore Chennai-600004. inter alia to consider and approve: Fixing the date time and mode/venue for the 36thAnnual General Meeting (AGM). The Boards Report its annexures and the Notice of the AGM for the FY ended March 31 2026. Book closure dates and the Record Date / Cut-off Date for e-voting purposes. Appointment of the Scrutinizer for the e-voting process. Any other business / items with the permission of the Chair.Kindly take on record.
1 week agoChennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on 28th August 2026 Friday at the Registered Office of the Company situated at New. No. 70 Old No.149 Luz Church Road Mylapore Chennai-600004. inter alia to consider and approve: Fixing the date time and mode/venue for the 36thAnnual General Meeting (AGM). The Boards Report its annexures and the Notice of the AGM for the FY ended March 31 2026. Book closure dates and the Record Date / Cut-off Date for e-voting purposes. Appointment of the Scrutinizer for the e-voting process. Any other business / items with the permission of the Chair.Kindly take on record.
1 week agoPursuant to Regulation 47 and other applicable provisions of SEBI (LODR) Regulations 2015 please find enclosed herewith copies of the newspaper advertisement published by the Company regarding the Unaudited financial results for the Quarter ended 30th June 2026.The unaudited financial results were considered approved and taken on record by the Board of Directors of the Company at its meeting held on 11th August 2026.The advertisement published on 13th August 2026 in Financial Express-English and Makkal Kural-Tamil on 12th August 2026.The newspaper clipping are also being made available on the website of the Company at www.cmmh.in
3 weeks agoPursuant to Regulation 47 and other applicable provisions of SEBI (LODR) Regulations 2015 please find enclosed herewith copies of the newspaper advertisement published by the Company regarding the Unaudited financial results for the Quarter ended 30th June 2026.The unaudited financial results were considered approved and taken on record by the Board of Directors of the Company at its meeting held on 11th August 2026.The advertisement published on 13th August 2026 in Financial Express-English and Makkal Kural-Tamil on 12th August 2026.The newspaper clipping are also being made available on the website of the Company at www.cmmh.in
3 weeks agoThe Board of Directors approved key management appointments and committee reconstitutions at its meeting held on August 11 2026. On the recommendation of the Nomination and Remuneration Committee Dr Thanigai Vendan Moorrthy has been appointed as Chief Executive Officer and Key Managerial Personnel for 5-years term starting from August 11 2026. Additionally Mr A F Simeon Telfer (DIN: 11879121) Mr Ramanuja Bharathi (DIN: 08553270) and MS Sindu Chawla (DIN: 11879201) have been appointed as Additional Directors in the capacity of Independent Directors for 5 years term starting August 11 2026 subject to shareholder approval at the ensuing Annual General Meeting. Following these appointments the Board also reconstituted its Audit Committee and Stakeholders Relationship Committee effective August 11 2026.
3 weeks agoThe Board of Directors approved key management appointments and committee reconstitutions at its meeting held on August 11 2026. On the recommendation of the Nomination and Remuneration Committee Dr Thanigai Vendan Moorrthy has been appointed as Chief Executive Officer and Key Managerial Personnel for 5-years term starting from August 11 2026. Additionally Mr A F Simeon Telfer (DIN: 11879121) Mr Ramanuja Bharathi (DIN: 08553270) and MS Sindu Chawla (DIN: 11879201) have been appointed as Additional Directors in the capacity of Independent Directors for 5 years term starting August 11 2026 subject to shareholder approval at the ensuing Annual General Meeting. Following these appointments the Board also reconstituted its Audit Committee and Stakeholders Relationship Committee effective August 11 2026.
3 weeks agoThe Board of Directors approved Key Management Appointments and committee reconstitutions at its meeting held on 11th August 2026. On the recommendation of Nomination and Remuneration Committee Dr Thanigai Vendan Moorrthy has been appointed as Chief Executive Officer (in non director capacity) for a term of 5 years. Additionally Mr A F Simeon Telfer (DIN: 11879121) Mr R V Ramanuja Bharathi (DIN: 08553270) and Ms Sindu Chawla (DIN: 11879201) have been appointed as Additional Directors in the capacity of Non Executive Independent Director for a 5 years term starting August 11 2026 subject to shareholder approval at the ensuing Annual General Meeting. Following these appointments the Board also reconstituted its Audit Committee and Stakeholder Relationship Committee effective August 11 2026.
3 weeks agoThe Board of Directors approved Key Management Appointments and committee reconstitutions at its meeting held on 11th August 2026. On the recommendation of Nomination and Remuneration Committee Dr Thanigai Vendan Moorrthy has been appointed as Chief Executive Officer (in non director capacity) for a term of 5 years. Additionally Mr A F Simeon Telfer (DIN: 11879121) Mr R V Ramanuja Bharathi (DIN: 08553270) and Ms Sindu Chawla (DIN: 11879201) have been appointed as Additional Directors in the capacity of Non Executive Independent Director for a 5 years term starting August 11 2026 subject to shareholder approval at the ensuing Annual General Meeting. Following these appointments the Board also reconstituted its Audit Committee and Stakeholder Relationship Committee effective August 11 2026.
3 weeks agoWe wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 11th August 2026 (commenced at 11:30 AM and concluded at 3:00 PM) inter-alia approved the Unaudited Financial Results along with the Limited Review Report for the quarter ended 30th June 2026 under Regulation 33 of SEBI LODR the appointment of Dr. Thanigai Vendan Moorrthy (PAN: ADUPT0825B) as CEO (in Non-Director capacity) & KMP for a 5-year term w.e.f. 11th August 2026 the appointments of Mr. A F Simeon Telfer (DIN: 11879121) Mr. R V Ramanuja Bharathi (DIN: 08553270) and Ms. Sindu Chawla (DIN: 11879201) as Additional Non-Executive Independent Directors for a 5-year term w.e.f. 11th August 2026 (subject to shareholder approval at the ensuing AGM) and the consequential reconstitution of the Audit Committee and Stakeholders Relationship Committee w.e.f. 11th August 2026.
3 weeks agoWe wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 11th August 2026 (commenced at 11:30 AM and concluded at 3:00 PM) inter-alia approved the Unaudited Financial Results along with the Limited Review Report for the quarter ended 30th June 2026 under Regulation 33 of SEBI LODR the appointment of Dr. Thanigai Vendan Moorrthy (PAN: ADUPT0825B) as CEO (in Non-Director capacity) & KMP for a 5-year term w.e.f. 11th August 2026 the appointments of Mr. A F Simeon Telfer (DIN: 11879121) Mr. R V Ramanuja Bharathi (DIN: 08553270) and Ms. Sindu Chawla (DIN: 11879201) as Additional Non-Executive Independent Directors for a 5-year term w.e.f. 11th August 2026 (subject to shareholder approval at the ensuing AGM) and the consequential reconstitution of the Audit Committee and Stakeholders Relationship Committee w.e.f. 11th August 2026.
3 weeks agoPursuant to Regulation 30 of SEBI (LODR) 2015 we wish to inform you that the Board of Director of the Company at its Meeting held today August 7 2026 via video conferencing (commenced at 12.30PM and concluded at 1.45PM) has inter-alia approved the following:1. Appointment of Independent Director: Based on recommendation of Nomination and Remuneration committee Mr M Karunakaran (DIN:11874200) has been appointed as an Additional Director (Non-Executive Independent) for a term of 5 consecutive years w.e.f. August 7 2026 subject to shareholder approval at ensuing AGM.2. Reconstitution of Committees: Consequent to this appointment the Audit Committee Nomination & Remuneration Committee and Stakeholder Relationship Committee stand reconstituted w.e.f August 7 2026.Kindly take the above on record.
4 weeks agoPursuant to Regulation 30 of SEBI (LODR) 2015 we wish to inform you that the Board of Director of the Company at its Meeting held today August 7 2026 via video conferencing (commenced at 12.30PM and concluded at 1.45PM) has inter-alia approved the following:1. Appointment of Independent Director: Based on recommendation of Nomination and Remuneration committee Mr M Karunakaran (DIN:11874200) has been appointed as an Additional Director (Non-Executive Independent) for a term of 5 consecutive years w.e.f. August 7 2026 subject to shareholder approval at ensuing AGM.2. Reconstitution of Committees: Consequent to this appointment the Audit Committee Nomination & Remuneration Committee and Stakeholder Relationship Committee stand reconstituted w.e.f August 7 2026.Kindly take the above on record.
4 weeks agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today August 7 2026 via video conferencing (commenced at 12:30 PM and concluded at 1:45 PM) has inter-alia approved the following:Appointment of Independent Director: Based on the recommendation of the Nomination and Remuneration Committee Mr. M. Karunakaran (DIN: 11874200) has been appointed as an Additional Director (Non-Executive Independent) for a term of 5 consecutive years w.e.f. August 7 2026 subject to shareholder approval at the ensuing AGM.Reconstitution of Committees: Consequent to this appointment the Audit Committee Nomination & Remuneration Committee and Stakeholders Relationship Committee stand reconstituted w.e.f. August 7 2026.
4 weeks agoPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today August 7 2026 via video conferencing (commenced at 12:30 PM and concluded at 1:45 PM) has inter-alia approved the following:Appointment of Independent Director: Based on the recommendation of the Nomination and Remuneration Committee Mr. M. Karunakaran (DIN: 11874200) has been appointed as an Additional Director (Non-Executive Independent) for a term of 5 consecutive years w.e.f. August 7 2026 subject to shareholder approval at the ensuing AGM.Reconstitution of Committees: Consequent to this appointment the Audit Committee Nomination & Remuneration Committee and Stakeholders Relationship Committee stand reconstituted w.e.f. August 7 2026.
4 weeks agoChennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Pursuant to Regulations 29(1)(a) and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended NOTICE is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday August 11 2026 at 11:30 A.M. at the Registered Office of the Company at New No. 70 Old No. 149 Luz Church Road Mylapore Chennai - 600 004 inter-alia to consider approve and take on record:1. Unaudited Financial Results of the Company for the quarter ended June 30 2026.2. Any other business item(s) with the permission of the Chair.Trading Window Closure:In continuation to our letter (Ref: CMMH/BSE/2026-27/24 dated June 29 2026) and under SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the Companys shares by Directors Designated Employees Insiders and immediate relatives remains closed from July 1 2026 until 48 hours after the declaration of the financial results.
4 weeks agoChennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Pursuant to Regulations 29(1)(a) and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended NOTICE is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday August 11 2026 at 11:30 A.M. at the Registered Office of the Company at New No. 70 Old No. 149 Luz Church Road Mylapore Chennai - 600 004 inter-alia to consider approve and take on record:1. Unaudited Financial Results of the Company for the quarter ended June 30 2026.2. Any other business item(s) with the permission of the Chair.Trading Window Closure:In continuation to our letter (Ref: CMMH/BSE/2026-27/24 dated June 29 2026) and under SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the Companys shares by Directors Designated Employees Insiders and immediate relatives remains closed from July 1 2026 until 48 hours after the declaration of the financial results.
4 weeks agoChennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of Chennai Meenakshi Multispeciality Hospital Limited will be held on 7th August 2026 at 12.30 IST via Video Conference to consider and approve the appointment of M. Karunakaran (DIN: 11874200) as an Additional (Independent) Director of the Company.The meeting is convened at short notice under Section 173(3) of the Companies Act 2013 and SS-1 with the required consent of the Independent Director being obtained. Kindly take this on record.
4 weeks agoChennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of Chennai Meenakshi Multispeciality Hospital Limited will be held on 7th August 2026 at 12.30 IST via Video Conference to consider and approve the appointment of M. Karunakaran (DIN: 11874200) as an Additional (Independent) Director of the Company.The meeting is convened at short notice under Section 173(3) of the Companies Act 2013 and SS-1 with the required consent of the Independent Director being obtained. Kindly take this on record.
4 weeks agoPursuant to provisions of Section 178 and other applicable provisions if any of the Companies Act 2013 read with the Rules made thereunder and Regulation 19 read with Regulation 15(2) of the SEBI(LODR) we wish to inform you that the Board of Directors of the Company vide Circular resolution passed on 4 August 2026 has approved the reconstitution of Nomination and Remuneration Committee.
1 month agoPursuant to provisions of Section 178 and other applicable provisions if any of the Companies Act 2013 read with the Rules made thereunder and Regulation 19 read with Regulation 15(2) of the SEBI(LODR) we wish to inform you that the Board of Directors of the Company vide Circular resolution passed on 4 August 2026 has approved the reconstitution of Nomination and Remuneration Committee.
1 month agoPursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations 2015 as amended from time to time and in accordance with the SEBI Circular HO/38/13/11(2)2026 MIRSD-POD/1/3750/2026 dated 30th January 2026 we hereby enclose the copies of the newspaper advertisement published for the Equity Shareholders of the Company regarding the Special Window for Transfer and Dematerialization of Physical Securities.The said advertisement was published in Financial Express and Makkal Kural Newspaper on Tuesday 21st July 2026.
1 month agoPursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations 2015 as amended from time to time and in accordance with the SEBI Circular HO/38/13/11(2)2026 MIRSD-POD/1/3750/2026 dated 30th January 2026 we hereby enclose the copies of the newspaper advertisement published for the Equity Shareholders of the Company regarding the Special Window for Transfer and Dematerialization of Physical Securities.The said advertisement was published in Financial Express and Makkal Kural Newspaper on Tuesday 21st July 2026.
1 month agoPursuant to Regulation 39(3) of the SEBI (LODR) Regulations 2015. We wish to inform that the company has issued Duplicate Share Certificates as detailed below:Name of shareholder : Mr. Bharat Chheda Jt. Ms. Usha ChhedaFolio No. 00012111Certificate No. (Original) 17926 17927 - (Duplicate) 44885.Distinctive No. From 3080801 TO 3080900 and From 3080901 TO 3081000No of shares : 200 Duplicate share Cert issued on : 16.07.2026RTA Cameo Letter received on : 21.07.2026.
1 month agoPursuant to Regulation 39(3) of the SEBI (LODR) Regulations 2015. We wish to inform that the company has issued Duplicate Share Certificates as detailed below:Name of shareholder : Mr. Bharat Chheda Jt. Ms. Usha ChhedaFolio No. 00012111Certificate No. (Original) 17926 17927 - (Duplicate) 44885.Distinctive No. From 3080801 TO 3080900 and From 3080901 TO 3081000No of shares : 200 Duplicate share Cert issued on : 16.07.2026RTA Cameo Letter received on : 21.07.2026.
1 month agoCertificate under Regulation 74(5) SEBI (DP) Regulations 2018 as amended for the quarter ended 30th June 2026. Based on the confirmation received from Cameo Corporate Services Limited Registrar and Share Transfer Agent of the Company we hereby certify that the securities received for dematerialisation have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within stipulated time line under captioned regulations and details are furnished to the stock exchange. Further we certify that the securities which were dematerialised are listed on BSE Limited where the earlier issued securities are listed.
1 month agoCertificate under Regulation 74(5) SEBI (DP) Regulations 2018 as amended for the quarter ended 30th June 2026. Based on the confirmation received from Cameo Corporate Services Limited Registrar and Share Transfer Agent of the Company we hereby certify that the securities received for dematerialisation have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within stipulated time line under captioned regulations and details are furnished to the stock exchange. Further we certify that the securities which were dematerialised are listed on BSE Limited where the earlier issued securities are listed.
1 month agoPursuant to Provisions of SEBI (Prohibition of Insider Trading) Regulation 2015 as amended read with Companys Code on Prevention of Insider Trading it is hereby informed that the Trading Window for the purpose of transaction in the Companys share(s) by the Directors Designated Employees other insiders of the Company and their relatives will remain closed from 1st July 2026 till the completion of 48 hours after the declaration of Unaudited financial results for the Quarter ended 30th June 2026. Accordingly all the designated employees other insiders of the Company (including Directors) and their relatives have been intimated not to trade in the Companys share(s) during the aforesaid period of closure of Trading Window. The date of Board Meeting to consider approve and take on record the Unaudited financial results for the Quarter ended 30th June 2026 shall be intimated to the Stock Exchange in due course.
2 months agoPursuant to Provisions of SEBI (Prohibition of Insider Trading) Regulation 2015 as amended read with Companys Code on Prevention of Insider Trading it is hereby informed that the Trading Window for the purpose of transaction in the Companys share(s) by the Directors Designated Employees other insiders of the Company and their relatives will remain closed from 1st July 2026 till the completion of 48 hours after the declaration of Unaudited financial results for the Quarter ended 30th June 2026. Accordingly all the designated employees other insiders of the Company (including Directors) and their relatives have been intimated not to trade in the Companys share(s) during the aforesaid period of closure of Trading Window. The date of Board Meeting to consider approve and take on record the Unaudited financial results for the Quarter ended 30th June 2026 shall be intimated to the Stock Exchange in due course.
2 months agoPursuant to Regulation 30 of SEBI (LODR) 2015 we would like to inform you that Dr. Venkataraman Krishnamurthy vide his letter dated 15th June 2026 has tendered his resignation as Chief Executive Officer of the Company with effect from close of business hours on 15th June 2026 due to his personal reasons. You are requested to take the above on record.
2 months agoPursuant to Regulation 30 of SEBI (LODR) 2015 we would like to inform you that Dr. Venkataraman Krishnamurthy vide his letter dated 15th June 2026 has tendered his resignation as Chief Executive Officer of the Company with effect from close of business hours on 15th June 2026 due to his personal reasons. You are requested to take the above on record.
2 months agoPursuant to Reg 30 read with Schedule III Part A Para A of SEBI LODR as amended from time to time and in accordance with SEBI Circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January 2026 we hereby enclose the copies of Advertisement published for Equity Shareholders of the Company regarding the special window for transfer and dematerialisation of physical securities.
2 months agoPursuant to Reg 30 read with Schedule III Part A Para A of SEBI LODR as amended from time to time and in accordance with SEBI Circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated 30th January 2026 we hereby enclose the copies of Advertisement published for Equity Shareholders of the Company regarding the special window for transfer and dematerialisation of physical securities.
2 months agoWith reference to the Communication Module Queries raised by BSE regarding Shareholding Pattern filed under Regulation 31 of SEBI (LODR) we hereby submit a comprehensive clarification. The discrepancies highlighted across the previous quarters (June 2024 till December 2025) have been clarified in the letter along with a summary table explaining all details in one sheet. Please take this into record and close the status of discrepancies in communication module.
2 months agoWith reference to the Communication Module Queries raised by BSE regarding Shareholding Pattern filed under Regulation 31 of SEBI (LODR) we hereby submit a comprehensive clarification. The discrepancies highlighted across the previous quarters (June 2024 till December 2025) have been clarified in the letter along with a summary table explaining all details in one sheet. Please take this into record and close the status of discrepancies in communication module.
2 months agoPursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI Listing Obligation and Disclosure Requirements Regulation 2015 we hereby inform you that Mr Nagayasamy Rajkumar DIN 00617000 has completed his 5 year tenure as Independent Director of the Company. Consequently he ceases to be an Independent Director of the Company with effect from the close of business hours on June 8 2026. The detailed disclosure as required under Regulation 30 of SEBI LODR Regulation read with SEBI circulars is enclosed herewith as Annexure A. We request you to kindly take the above information on your record.
2 months ago1. Name of shareholder : Sathyanath Pai BFolio No. 00011595; Original cert no.17175; Duplicate cert. no. 44883 ; Distinctive No. From 3005701 To 3005800; No. of shares : 100; Duplicate share cert. issued on 28.05.2026; Cameo (RTA) letter received by company on 5.06 2026.*******2. Name of shareholder : Shantilal Padmashi Shah (existing name) Shantilal Padamshi Shah (new name). Folio No. 00018370 ; Original cert.no. 5007; Duplicate cert. no. 44884 ; Distinctive No. From 1788901 To 1789000; No. of shares : 100 ;Duplicate share cert. issued on 03.06.2026: Cameo (RTA) letter received by company on 5.06.2026.
2 months ago1. Name of shareholder : Sathyanath Pai BFolio No. 00011595; Original cert no.17175; Duplicate cert. no. 44883 ; Distinctive No. From 3005701 To 3005800; No. of shares : 100; Duplicate share cert. issued on 28.05.2026; Cameo (RTA) letter received by company on 5.06 2026.*******2. Name of shareholder : Shantilal Padmashi Shah (existing name) Shantilal Padamshi Shah (new name). Folio No. 00018370 ; Original cert.no. 5007; Duplicate cert. no. 44884 ; Distinctive No. From 1788901 To 1789000; No. of shares : 100 ;Duplicate share cert. issued on 03.06.2026: Cameo (RTA) letter received by company on 5.06.2026.
2 months agoIn continuation to the Letter submitted by Chennai Meenakshi Multispeciality Hospital Limited bearing reference No. CMMH/BSEE/2026-27/06 dated April 21 2026. We would like to inform you that pursuant to Regulation 15(2) of SEBI (LODR) Regulations 2015 the compliance with the Corporate Governance provisions as specified in Reg 17 17A 18 19 20 21 22 23 24 24A 25 26 27 and clauses (b) to (i) of sub-regulations (2) of Regulation 46 and para C D and E of Schedule V shall not apply in respect of our company as the paid up equity share capital of does not exeed Rupees ten crores and net worth does not exceed rupees twenty five crores as on the last day of the previous financial year i.e. 31st March 2026.
3 months agoIn continuation to the Letter submitted by Chennai Meenakshi Multispeciality Hospital Limited bearing reference No. CMMH/BSEE/2026-27/06 dated April 21 2026. We would like to inform you that pursuant to Regulation 15(2) of SEBI (LODR) Regulations 2015 the compliance with the Corporate Governance provisions as specified in Reg 17 17A 18 19 20 21 22 23 24 24A 25 26 27 and clauses (b) to (i) of sub-regulations (2) of Regulation 46 and para C D and E of Schedule V shall not apply in respect of our company as the paid up equity share capital of does not exeed Rupees ten crores and net worth does not exceed rupees twenty five crores as on the last day of the previous financial year i.e. 31st March 2026.
3 months agoPursuant to Regulation 47 and other applicable provisions of SEBI (LODR) Regulations 2015 please find enclosed herewith copies of the newspaper advertisement published by the Company regarding the Audited financial results for Quarter & financial year ended 31st March 2026.The audited financial results were considered approved and taken on record by the Board of Directors of the Company at its meeting held on 25th May 2026. The advertisement published on 26th May 2026 in Financial Express-English and Makkal Kural -Tamil.The newspaper clipping are also being made available on the website of the Company at www.cmmh.in.
3 months agoPursuant to Regulation 47 and other applicable provisions of SEBI (LODR) Regulations 2015 please find enclosed herewith copies of the newspaper advertisement published by the Company regarding the Audited financial results for Quarter & financial year ended 31st March 2026.The audited financial results were considered approved and taken on record by the Board of Directors of the Company at its meeting held on 25th May 2026. The advertisement published on 26th May 2026 in Financial Express-English and Makkal Kural -Tamil.The newspaper clipping are also being made available on the website of the Company at www.cmmh.in.
3 months agoThe Board approved the audited financial results for the quarter and financial year ended 31st March 2026. No dividend was recommended.
3 months agoThe Board approved the audited financial results for the quarter and financial year ended 31st March 2026. No dividend was recommended.
3 months agoThis is to intimate that the Board of Directors of the Company at its meeting held on Monday May 25 2026 at the registered office of the Company have inter alia approved the Audited Financial Results for the quarter and financial year ended 31st March 2026. The Board of Directors have not recommended any Dividend for the year 2025-26.The approved Audited Financial Results along with audit report Cash Flow Statement for the year ended 31st March 2026 and declaration on the report of auditors with unmodified opinion are enclosed with this letter.Further we would like to inform that the financial results will be published in the newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The financial results are also available on the Companys website - www.cmmh.in.The meeting commenced at 12:00 Hours and concluded at 15:00 Hours.
3 months agoThis is to intimate that the Board of Directors of the Company at its meeting held on Monday May 25 2026 at the registered office of the Company have inter alia approved the Audited Financial Results for the quarter and financial year ended 31st March 2026. The Board of Directors have not recommended any Dividend for the year 2025-26.The approved Audited Financial Results along with audit report Cash Flow Statement for the year ended 31st March 2026 and declaration on the report of auditors with unmodified opinion are enclosed with this letter.Further we would like to inform that the financial results will be published in the newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The financial results are also available on the Companys website - www.cmmh.in.The meeting commenced at 12:00 Hours and concluded at 15:00 Hours.
3 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Old No. 149, New No. 70 Luz Church Road Mylapore Chennai Tamil Nadu PIN: 600004 Tel No: 044 - 42938938 Fax No: 044 - 24993282 Email: [email protected] Internet: www.cmmh.in
Registrars
Subramanian Buildings No 1 , Club House Road,,Chennai Subramanian Buildings No 1 Club House Road NULL PIN: Tel No: 044-28460390/28460394 Fax No: 044-28460129 Email: NULL
Management
R Gomathi, Chairman & Managing Director
R Gomathi, Chairman & Managing Director
Jayanthi Radhakrishnan, Managing Director
Edward M Prabhakar, Non Independent & Non Executive Director
Akash Prabhakar, Non Executive Director
Shama Dhilip, Non Executive Independent Director
MS Anantha Lakshmi, Company Secretary and Compliance Officer
Details
BSE 523489
NSE NULL
ISIN INE889F01017